Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - DUSA PHARMACEUTICALS INC | Financial_Report.xls |
| EX-31.B - EX-31.B - DUSA PHARMACEUTICALS INC | y92980exv31wb.htm |
| EX-99.1 - EX-99.1 - DUSA PHARMACEUTICALS INC | y92980exv99w1.htm |
| EX-31.A - EX-31.A - DUSA PHARMACEUTICALS INC | y92980exv31wa.htm |
| EX-32.B - EX-32.B - DUSA PHARMACEUTICALS INC | y92980exv32wb.htm |
| 10-Q - FORM 10-Q - DUSA PHARMACEUTICALS INC | y92980e10vq.htm |
EXHIBIT 32(A)
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of DUSA Pharmaceuticals, Inc.(the “Company”) on Form 10-Q
for the period ending September 30, 2011, as filed with the Securities and Exchange Commission (the
“Report”), I, Robert F. Doman, President and Chief Executive Officer of the Company, certify,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that:
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934; and
The information contained in the Report fairly presents, in all material respects, the financial
condition and results of operations of the Company.
| /s/ Robert F. Doman | ||||
| Robert F. Doman | ||||
| President and Chief Executive Officer (principal executive officer) |
||||
Date: November 10, 2011
A signed original of this written statement required by Section 906, or other document
authenticating, acknowledging, or otherwise adopting the signature that appears in typed form
within the electronic version of this written statement required by Section 906, has been provided
to the Company and will be retained by the Company and furnished to the Securities and Exchange
Commission or its staff upon request.